CIK 0001001233
- Non-accelerated filer
- Smaller reporting company
SANGAMO THERAPEUTICS, INC
Sign in to watch- Ticker
- SGMOQ
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680359556
- Phone
- +1 510-970-6000
- Business address
- 501 CANAL BLVD., RICHMOND, CA, 94084
- Former names
- SANGAMO BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-25 | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | Shares withheld for taxes | −1,336 | $0.60 | $802 | 833,694 |
| 2024-05-25 | Pooler Amy VP, HEAD OF RESEARCH | Shares withheld for taxes | −493 | $0.60 | $296 | 195,119 |
| 2024-05-25 | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,371 | $0.60 | $823 | 831,420 |
| 2024-05-25 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −7,492 | $0.60 | $4K | 2,539,451 |
| 2024-05-24 | Dubois-Stringfellow Nathalie SVP-CHIEF DEVELOPMENT OFFICER | Shares withheld for taxes | −1,787 | $0.60 | $1K | 844,401 |
| 2024-05-24 | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | Shares withheld for taxes | −1,400 | $0.60 | $840 | 835,030 |
| 2024-05-24 | Pooler Amy VP, HEAD OF RESEARCH | Shares withheld for taxes | −702 | $0.60 | $421 | 195,612 |
| 2024-05-24 | Duraibabu Prathyusha SVP, CHIEF FINANCIAL OFFICER | Shares withheld for taxes | −1,787 | $0.60 | $1K | 832,791 |
| 2024-05-24 | Macrae Sandy PRESIDENT, CEO AND DIRECTOR | Shares withheld for taxes | −5,261 | $0.60 | $3K | 2,546,943 |
| 2024-02-25 | Pooler Amy VP, HEAD OF RESEARCH | Shares withheld for taxes | −2,459 | $1.13 | $3K | 196,314 |
| 2024-02-25 | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | Shares withheld for taxes | −3,453 | $1.13 | $4K | 836,430 |
| 2024-02-24 | Pooler Amy VP, HEAD OF RESEARCH | Shares withheld for taxes | −2,209 | $1.13 | $2K | 198,773 |
| 2024-02-24 | Willoughby Scott B. SVP, GEN. COUNSEL & SECRETARY | Shares withheld for taxes | −4,379 | $1.13 | $5K | 839,883 |
| 2023-09-26 | BIOGEN INC. 10% owner | Sale | −6,000,000 | $0.50 | $3.0M | 17,652,466 |
| 2022-08-30 | BIOGEN INC. 10% owner | Sale | −100,000 | $5.27 | $527K | 23,652,466 |
| 2022-08-29 | BIOGEN INC. 10% owner | Sale | −400,000 | $5.33 | $2.1M | 23,752,466 |
| 2021-12-28 | BIOGEN INC. 10% owner | Sale | −2,764 | $8.51 | $24K | 24,152,466 |
| 2021-12-27 | BIOGEN INC. 10% owner | Sale | −600 | $8.56 | $5K | 24,155,230 |
| 2021-12-23 | BIOGEN INC. 10% owner | Sale | −81,187 | $8.55 | $695K | 24,155,830 |
| 2021-12-09 | BIOGEN INC. 10% owner | Sale | −23,660 | $8.56 | $203K | 24,237,017 |
Page 8 of 9 · 165 trades